Man Group plc - CATALYST PHARMACEUTICALS INC ownership

CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 254 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.

Quarter-by-quarter ownership
Man Group plc ownership history of CATALYST PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$7,944,255
-29.2%
679,577
-18.6%
0.02%
-28.6%
Q2 2023$11,222,508
-24.8%
835,008
-7.2%
0.04%
-34.0%
Q1 2023$14,919,065
-9.8%
899,823
+1.2%
0.05%
-10.2%
Q4 2022$16,545,295
+63.8%
889,532
+13.0%
0.06%
+25.5%
Q3 2022$10,098,000
+372.5%
787,100
+158.2%
0.05%
+422.2%
Q2 2022$2,137,000
+0.7%
304,800
+19.0%
0.01%
+28.6%
Q1 2022$2,123,000
-20.2%
256,100
-34.8%
0.01%
-22.2%
Q4 2021$2,660,000
+64.1%
392,900
+28.4%
0.01%
+50.0%
Q3 2021$1,621,000
-7.8%
305,9000.0%0.01%0.0%
Q2 2021$1,759,000
+4.8%
305,900
-16.0%
0.01%
-14.3%
Q1 2021$1,679,000
-49.4%
364,227
-63.3%
0.01%
-53.3%
Q4 2020$3,318,000
-1.6%
993,562
-12.5%
0.02%
+15.4%
Q3 2020$3,371,000
-30.5%
1,135,062
+8.1%
0.01%
-45.8%
Q2 2020$4,850,000
+1063.1%
1,049,735
+869.3%
0.02%
+700.0%
Q1 2020$417,000
+50.5%
108,300
+46.7%
0.00%
+200.0%
Q4 2019$277,00073,8000.00%
Other shareholders
CATALYST PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
TANAKA CAPITAL MANAGEMENT INC 148,281$2,4587.14%
GABLES CAPITAL MANAGEMENT INC. 409,080$6,782,5464.74%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 10,355,099$171,687,5413.83%
JW Asset Management, LLC 563,392$9,341,0393.58%
Quantedge Capital Pte Ltd 324,700$5,383,5262.10%
Paradiem, LLC 236,628$3,923,2921.22%
SummerHaven Investment Management, LLC 100,592$1,667,8150.97%
Capital Impact Advisors, LLC 46,096$764,2720.94%
Yorktown Management & Research Co Inc 50,000$829,0000.89%
Seaport Global Advisors, LLC 15,598$258,6150.82%
View complete list of CATALYST PHARMACEUTICALS INC shareholders